<DOC>
	<DOCNO>NCT01207947</DOCNO>
	<brief_summary>Main object investigate safety profile Levitra combination use alpha-blockers patient erectile dysfunction use clinical practice launch . In initial combination date first second observation initial combination date , number tablet prescribe , dose tablet number tablet take follow-up visit investigate . The efficacy tolerability evaluate 2 month initial combination date .</brief_summary>
	<brief_title>LEVITRAÂ® Specific Drug Use Investigation . To Investigate Safety Profile Combination Use With Alpha-blockers</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<criteria>Patients &gt; /= 18 year Enrollment within 7 day initiation combination use Levitra alphablockers</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Vardenafil</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Phosphodiesterase Inhibitors</keyword>
	<keyword>Combination use alpha-blocker</keyword>
</DOC>